N-((2S,3R)-1,3-Dihydroxyoctadecan-2-yl)hexanamide

Catalog No. :
ACUVCM213
CAS No. :
171039-13-7
Molecular Formula :
C24H49NO3
Molecular Weight :
399.66

IUPAC Name:N-((2S,3R)-1,3-dihydroxyoctadecan-2-yl)hexanamide

N-((2S,3R)-1,3-Dihydroxyoctadecan-2-yl)hexanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$317.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((2S,3R)-1,3-Dihydroxyoctadecan-2-yl)hexanamide
IUPAC NameN-((2S,3R)-1,3-dihydroxyoctadecan-2-yl)hexanamide
Molecular FormulaC24H49NO3
Molecular Weight399.66
SMILES[C@H](CO)([C@H](O)CCCCCCCCCCCCCCC)NC(=O)CCCCC
InChI KeyVUMHYWBWYSPQMM-XZOQPEGZSA-N
SynonymSCHEMBL6236415 | C6 dihydro Ceramide (d18:0/6:0) | N-Hexanoyldihydrosphingosine | C6 Dihydroceramide | BP-28808 | MFCD01320384 | (2S,3R)-Dihydroceramide | N-hexanoylsphinganine | N-hexanoyl-sphinganine | Q27145820 | C6-dihydroceramide | CHEBI:76226 | C6 D
CAS No.171039-13-7
PubChem CID16219163

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACUVCM213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRFGT640 route compound structure diagram
    ACRFGT64010051-44-2 In Stock
  2. Plus
  3. ACILWA013 route compound structure diagram
    ACILWA013764-22-7 In Stock
  4. Then
  5. ACUVCM213 route product structure diagram
    ACUVCM213171039-13-7
Inquiry

2. ACUVCM213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACILWA013 route compound structure diagram
    ACILWA013764-22-7 In Stock
  4. Then
  5. ACUVCM213 route product structure diagram
    ACUVCM213171039-13-7
Inquiry

Comments (0)